|
|
|
Areas of
Research
Stem Cell Types
Due to the impressive breadth of investigator
expertise, the scope of non-embryonic stem cell types
under study within the Center is comprised of nine cell
types:
| ASC |
Adipose Stem Cells |
| CTP |
Connective Tissue Progenitor
Cells |
| HSC |
Hematopoietic Stem Cells |
| HB1 |
Hemangioblast (AC133) derived from umbilical
cord blood |
| MAPC |
Multi-potent Adult Stem Cells |
| MSC |
Mesenchymal Stem Cells |
| NSC |
Neural Stem Sells/oligodendrocyte progenitors
|
| SKMB |
Skeletal Myoblasts |
| UCB |
Umbilical Cord Blood Derived Stem
Cells |
This collection of stem cells is being investigated
for therapeutic uses in musculoskeletal, cardiovascular,
hematopoietic and neurological disorders.
This collection of stem cells also is being
investigated for therapeutic uses in musculoskeletal,
cardiovascular, hematopoietic and neurological
disorders.
Cardiovascular and vascular
HSC,
HB1, MAPC
Myocardial regeneration with cell
homing, differentiation and regeneration, vascular
remodeling -- for ischemic, congestive and dilated
cardiomyopathy.
|
Hematopoietic and cancer
HSC,
HB1, MSC
UCB (umbilical cord blood) stem
cell expansion and transplantation, cytokine
directed differentiation for GVL (graft vs.
leukemia), marrow reconstitution and stem cell
selection, HSC gene transfer, MSC modulation of
GVHD (graft vs. host disease), -- for curing
cancer allogeneic transplantation, correction of
genetic diseases and protection from
chemotherapy.
|
Neurodegenerative and
neurological
NSC, MAPC
Cell
implantation into brain and spinal cord for
neuronal or glial replacement therapy in
Neurodegenerative disorders – Huntington’s
disease, multiple sclerosis, amyotropic lateral
sclerosis and spinal cord injury.
|
Orthopedic and
Musculoskeletal
MSC, MAPC,
CTP
Bone and cartilage repair, MSC homing
factors, myoblast homing using surface molecule
“painting” -- for fractures, joint disease,
muscular
dystrophy.
| | | |
Headline
News
MSC2011 will be held August 22-24, 2011 in Cleveland, Ohio
The MSC2011 Conference on Regenerative Medicine and Adult Stem Cell Therapy will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. Become an active part of MSC2011 today—let us know if you have suggestions for speakers or topics, or would like to be involved in planning and implementation. Email registration@mscconference.net or call 1-216-368-2079 to submit your ideas.
For more information, please visit www.msc2011.net/.
|
|
|